Metabolite List

metabolites which its exact mass nearly 226.0994 with tolerance error 0.01 da.

Porphobilinogen (BioCAD00000016531)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Porphobilinogen (PBG) is a pyrrole-containing intermediate in the biosynthesis of porphyrins. It is generated from aminolevulinate (ALA) by the enzyme ALA dehydratase. Porphobilinogen is then converted into hydroxymethylbilane by the enzyme porphobilinogen deaminase (also known as hydroxymethylbilane synthase). Under certain conditions, porphobilinogen can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, and hereditary coproporphyria (HCP). There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503).

blood urine erythrocyte liver plant natural products microbial natural products
Carbidopa (BioCAD00000026024)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Carbidopa is only found in individuals that have used or taken this drug. It is an inhibitor of DOPA decarboxylase, preventing conversion of levodopa to dopamine. It is used in parkinson disease to reduce peripheral adverse effects of levodopa. It has no antiparkinson actions by itself. [PubChem]When mixed with levodopa, carbidopa inhibits the peripheral conversion of levodopa to dopamine and the decarboxylation of oxitriptan to serotonin by aromatic L-amino acid decarboxylase. This results in increased amount of levodopa and oxitriptan available for transport to the CNS. Carbidopa also inhibits the metabolism of levodopa in the GI tract, thus, increasing the bioavailability of levodopa.

blood urine
3'-Deoxythymidine (BioCAD00000176002)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

3'-Deoxythymidine is a natural product found in Petrosiidae with data available.

blood
DL-Carbidopa (BioCAD00000176025)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid is a monocarboxylic acid and a member of benzenes. An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.

blood
Cyclo(Glu-Pro) (BioCAD00000375804)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

PyroGlu-Pro (BioCAD00000500947)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

5-oxo-L-prolyl-proline (BioCAD00000502285)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Pelopurin B (BioCAD00000503718)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Cyclo(Pro-Glu) (BioCAD00000503891)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Cyclo(Pro-Glu) is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid.

carbidopa (anhydrous) (BioCAD00000537746)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

3-(3,4-Dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used (commonly as its hydrate) in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa." []

N-(3-hydroxypropyl)-4-methoxy-3-nitroaniline (BioCAD00000564067)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

proxibarbal (BioCAD00000571469)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

1-(5-Fluoro-2-methylphenyl)-3-propylthiourea (BioCAD00000668131)
Formula: C11H15FN2S (Exact Mass: 226.094)

Mebanazine oxalate (BioCAD00000684019)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

3'-Ketobutobarbitone (BioCAD00000693112)
Formula: C10H14N2O4 (Exact Mass: 226.0954)

Previcur (BioCAD00000703596)
Formula: C8H19ClN2OS (Exact Mass: 226.0907)

1-[(4-Fluorophenyl)methyl]benzimidazole (BioCAD00000759665)
Formula: C14H11FN2 (Exact Mass: 226.0906)